1. Basal microvilli define the metabolic capacity and lethal phenotype of pancreatic cancer. Issue 3 (22nd January 2021) Authors: Han, Xu; Ma, Lixiang; Gu, Jichun; Wang, Dansong; Li, Ji; Lou, Wenhui; Saiyin, Hexige; Fu, Deliang Journal: Journal of pathology Issue: Volume 253:Issue 3(2021) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway. (28th September 2019) Authors: Pu, Ning; Gao, Shanshan; Yin, Hanlin; Li, Jian-ang; Wu, Wenchuan; Fang, Yuan; Zhang, Lei; Rong, Yefei; Xu, Xuefeng; Wang, Dansong; Kuang, Tiantao; Jin, Dayong; Yu, Jun; Lou, Wenhui Journal: Cancer letters Issue: Volume 460(2019) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chk1 inhibitor SCH 900776 enhances the antitumor activity of MLN4924 on pancreatic cancer. Issue 2 (17th January 2018) Authors: Li, Jian-ang; Song, Chao; Rong, Yefei; Kuang, Tiantao; Wang, Dansong; Xu, Xuefeng; Yuan, Jian; Luo, Kuntian; Qin, Bo; Nowsheen, Somaira; Lou, Zhenkun; Lou, Wenhui Journal: Cell cycle Issue: Volume 17:Issue 2(2018) Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Circulating cytokines allow for identification of malignant intraductal papillary mucinous neoplasms of the pancreas. (24th July 2022) Authors: Pu, Ning; Chen, Qiangda; Zhang, Jicheng; Yin, Hanlin; Wang, Dansong; Ji, Yuan; Rao, Shengxiang; Kuang, Tiantao; Xu, Xuefeng; Wu, Wenchuan; Lou, Wenhui Journal: Cancer medicine Issue: Volume 12:Number 4(2023) Page Start: 3919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Analysis of Acinar Cell Carcinoma of the Pancreas: A Single-Center Experience of 45 Consecutive Cases. (28th October 2020) Authors: Zhou, Wentao; Han, Xu; Fang, Yuan; Han, Siyang; Cai, Yumeng; Kuang, Tiantao; Lou, Wenhui; Wang, Dansong Journal: Cancer control Issue: Volume 27:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology. Issue 2 (February 2018) Authors: Han, Xu; Xu, Xuefeng; Ma, Hongyun; Ji, Yuan; Wang, Dansong; Kuang, Tiantao; Wu, Wenchuan; Song, Bin; Li, Gang; Jin, Gang; Lou, Wenhui Journal: Endocrine connections Issue: Volume 7:Issue 2(2018) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Combined test of serum CgA and NSE improved the power of prognosis prediction of NF-pNETs. Issue 1 (January 2018) Authors: Lv, Yang; Han, Xu; Zhang, Chunyan; Fang, Yuan; Pu, Ning; Ji, Yuan; Wang, Dansong; Xuefeng, Xu; Lou, Wenhui Journal: Endocrine connections Issue: Volume 7:Issue 1(2018) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Current Role of Surgery in Pancreatic Cancer With Synchronous Liver Metastasis. (23rd November 2020) Authors: Zhou, Wentao; Wang, Dansong; Lou, Wenhui Journal: Cancer control Issue: Volume 27:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety comparison of nabpaclitaxel plus S-1 and gemcitabine plus S-1 as first-line chemotherapy for metastatic pancreatic cancer. (28th April 2018) Authors: Xu, Yaolin; Guo, Xi; Fan, Yue; Wang, Dansong; Wu, Wenchuan; Wu, Lili; Liu, Tianshu; Xu, Bei; Feng, Yi; Wang, Yan; Lou, Wenhui; Zhou, Yuhong Journal: Japanese journal of clinical oncology Issue: Volume 48:Number 6(2018) Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of S-1 based adjuvant chemoradiotherapy for resected pancreatic ductal adenocarcinoma with high-risk pathological feature: a prospective, single-arm, interventional study. Issue 1 (15th March 2022) Authors: Wu, Lili; Xu, Yaolin; Zeng, Zhaochong; Chen, Yixing; Zhou, Yuhong; Wang, Dansong; Sun, Jing; Lv, Minzhi; Du, Shisuo; Lou, Wenhui Journal: Journal of pancreatology Issue: Volume 5:Issue 1(2022) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗